1. Home
  2. CMCM vs LUNG Comparison

CMCM vs LUNG Comparison

Compare CMCM & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCM
  • LUNG
  • Stock Information
  • Founded
  • CMCM 2009
  • LUNG 1995
  • Country
  • CMCM China
  • LUNG United States
  • Employees
  • CMCM N/A
  • LUNG N/A
  • Industry
  • CMCM Computer Software: Prepackaged Software
  • LUNG Industrial Specialties
  • Sector
  • CMCM Technology
  • LUNG Health Care
  • Exchange
  • CMCM Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • CMCM 115.1M
  • LUNG 124.0M
  • IPO Year
  • CMCM 2014
  • LUNG 2020
  • Fundamental
  • Price
  • CMCM $4.50
  • LUNG $2.67
  • Analyst Decision
  • CMCM
  • LUNG Buy
  • Analyst Count
  • CMCM 0
  • LUNG 6
  • Target Price
  • CMCM N/A
  • LUNG $11.53
  • AVG Volume (30 Days)
  • CMCM 24.2K
  • LUNG 366.5K
  • Earning Date
  • CMCM 06-19-2025
  • LUNG 07-30-2025
  • Dividend Yield
  • CMCM N/A
  • LUNG N/A
  • EPS Growth
  • CMCM N/A
  • LUNG N/A
  • EPS
  • CMCM N/A
  • LUNG N/A
  • Revenue
  • CMCM $120,663,543.00
  • LUNG $87,473,000.00
  • Revenue This Year
  • CMCM $14.27
  • LUNG $18.02
  • Revenue Next Year
  • CMCM $39.26
  • LUNG $18.17
  • P/E Ratio
  • CMCM N/A
  • LUNG N/A
  • Revenue Growth
  • CMCM 27.02
  • LUNG 19.84
  • 52 Week Low
  • CMCM $3.02
  • LUNG $2.62
  • 52 Week High
  • CMCM $6.77
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • CMCM 63.43
  • LUNG 33.53
  • Support Level
  • CMCM $3.94
  • LUNG $2.62
  • Resistance Level
  • CMCM $4.31
  • LUNG $3.52
  • Average True Range (ATR)
  • CMCM 0.18
  • LUNG 0.23
  • MACD
  • CMCM -0.00
  • LUNG 0.02
  • Stochastic Oscillator
  • CMCM 79.45
  • LUNG 13.46

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: